Welcome to our dedicated page for Thermo Fisher Scientific news (Ticker: TMO), a resource for investors and traders seeking the latest updates and insights on Thermo Fisher Scientific stock.
Thermo Fisher Scientific, Inc. (TMO) is a global leader in providing science-based solutions, offering a wide range of products and services in the life sciences, analytical instruments, specialty diagnostics, and laboratory products sectors. The company's expansive portfolio includes scientific instruments, laboratory equipment, diagnostic consumables, and life science reagents, serving customers both in the United States and internationally.
Thermo Fisher operates through four distinct segments as of end-2023:
- Analytical Technologies (17% of sales): This segment focuses on providing high-quality instruments and software solutions for various scientific applications.
- Specialty Diagnostic Products (10% of sales): This segment specializes in offering diagnostic reagents and instruments for medical and research laboratories.
- Life Science Solutions (23% of sales): This segment provides reagents, instruments, and consumables used in biological research and drug development.
- Lab Products and Services (54% of sales): This is the largest segment, encompassing laboratory supplies, equipment, and contract research organization (CRO) services.
Thermo Fisher is continually expanding its offerings and capabilities through strategic partnerships, acquisitions, and technological innovation. The company's robust financial performance underscores its leadership in the industry, driven by consistent revenue growth, strong market presence, and a commitment to advancing scientific research and healthcare.
Recent achievements include technological advancements in analytical instruments, enhanced diagnostic solutions, and expanded biopharma services, reflecting Thermo Fisher's dedication to supporting life-saving research and diagnostic processes. Thermo Fisher remains committed to delivering high-quality products and services, fostering scientific breakthroughs, and maintaining its position at the forefront of scientific innovation.
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) has extended the expiration time of the offering period of its previously announced tender offer to acquire all outstanding common shares and American Depositary Shares of Olink Holding AB (publ) for $26.00 per Share and per ADS, in cash. The Offer is now scheduled to expire at 5:00 p.m., New York time, on January 3, 2024, unless extended or earlier terminated. Approximately 97.1% of the outstanding Shares have been validly tendered and not properly withdrawn pursuant to the Offer.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.67%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) has announced a 15-year virtual power purchasing agreement (VPPA) with international solar developer ib vogt for a 91-megawatt portion of the Serbal solar project. This will deliver approximately 192,000 megawatt hours of renewable electricity annually. Eurofins Scientific, a global leader in bioanalytical testing, is also involved in the deal for a 36-megawatt portion of the project. The project is expected to be operational in January 2025 and will power over half of Thermo Fisher's addressable European sites with 100% renewable electricity. Thermo Fisher has committed to achieving 80% renewable electricity globally by 2030 and reducing Scope 1 and 2 emissions by 50% by 2030 against a 2018 baseline.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) has extended the expiration time of the offering period of its tender offer to acquire all outstanding common shares and American Depositary Shares of Olink Holding AB (publ) for $26.00 per Share and per ADS, in cash. Approximately 95.2% of the outstanding Shares have been tendered and not properly withdrawn. Completion of the Offer is subject to conditions described in the tender offer statement on Schedule TO filed with the U.S. Securities and Exchange Commission on October 31, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.07%
Tags
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) announced a $2.5 billion aggregate principal amount offering of senior notes due in 2026, 2029, and 2034. The offering is expected to close soon.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) Announces $4 Billion Share Repurchase Authorization. The world leader in serving science, Thermo Fisher Scientific Inc., has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions, with no expiration date. This replaces the company’s existing repurchase authorization, of which $1 billion was remaining.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.17%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) announces a quarterly cash dividend of $0.35 per common share, payable on January 16, 2024, to shareholders of record as of December 15, 2023. This move reflects the company's commitment to rewarding its shareholders and its confidence in its financial position.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.94%
Tags
News
Rhea-AI Summary
Thermo Fisher Scientific Inc. has commenced a tender offer to acquire all outstanding common shares and ADSs of Olink Holding AB for $26.00 per share and per ADS in cash. The offer will expire on November 30, 2023, and is subject to regulatory approvals and a minimum tender condition. Olink's board of directors has recommended that shareholders accept the offer. Summa Equity AB and other shareholders holding approximately 66% of Olink's shares have entered into support agreements to tender into the offer.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific reports Q3 2023 financial results, with revenue of $10.57 billion, a 1% decrease from the same quarter last year. GAAP diluted EPS was $4.42, a 17% increase YoY. The company also announced an agreement to acquire Olink Holding AB for $3.1 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
-
Rhea-AI Summary
Thermo Fisher to acquire Olink for $3.1 billion, enhancing capabilities in the proteomics market
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
66.02%
Tags
Rhea-AI Summary
ViroCell Biologics appoints Traci Kyes as VP of Business Development (US) and Makis Sigalas as Senior Business Development Director (Europe) to drive growth in respective regions
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.73%
Tags
FAQ
What is the current stock price of Thermo Fisher Scientific (TMO)?
The current stock price of Thermo Fisher Scientific (TMO) is $513.08 as of November 15, 2024.
What is the market cap of Thermo Fisher Scientific (TMO)?
The market cap of Thermo Fisher Scientific (TMO) is approximately 196.7B.
What does Thermo Fisher Scientific, Inc. specialize in?
Thermo Fisher Scientific specializes in life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services.
What are the main segments of Thermo Fisher Scientific?
The main segments are Analytical Technologies, Specialty Diagnostic Products, Life Science Solutions, and Lab Products and Services.
How much of Thermo Fisher's sales come from Lab Products and Services?
Lab Products and Services account for 54% of Thermo Fisher's sales.
Where does Thermo Fisher Scientific operate?
Thermo Fisher Scientific operates both in the United States and internationally.
What recent achievements has Thermo Fisher Scientific made?
Recent achievements include advancements in analytical instruments, enhanced diagnostic solutions, and expanded biopharma services.
What is Thermo Fisher Scientific's stock symbol?
The stock symbol for Thermo Fisher Scientific is TMO.
How does Thermo Fisher Scientific support scientific research?
Thermo Fisher supports scientific research by providing high-quality instruments, reagents, and consumables essential for biological research and drug development.
What types of products does Thermo Fisher Scientific offer?
Thermo Fisher offers scientific instruments, laboratory equipment, diagnostic consumables, and life science reagents.
What is Thermo Fisher's commitment to the healthcare industry?
Thermo Fisher is committed to advancing scientific research and healthcare by delivering high-quality products, fostering scientific breakthroughs, and supporting life-saving research and diagnostic processes.
What sets Thermo Fisher Scientific apart in its industry?
Thermo Fisher's leadership stems from its diverse portfolio, strategic partnerships, technological innovation, and consistent financial performance.
Thermo Fisher Scientific, Inc.
NYSE:TMO
TMO Rankings
TMO Stock Data
196.72B
382.50M
0.18%
91.37%
0.8%
Diagnostics & Research
Measuring & Controlling Devices, Nec
United States of America
WALTHAM